Results 161 to 170 of about 2,713,068 (267)
Channel based generating function approach to the stochastic Hodgkin-Huxley neuronal system. [PDF]
Ling A, Huang Y, Shuai J, Lan Y.
europepmc +1 more source
mir‐196a promotes Esophagus Adenocarcinoma aggressiveness. On one hand, mir‐196a targets the valosin‐containing protein (VCP) mRNA, causing the accumulation of c‐MYC protein that leads to high amounts of TERT. On the other hand, mir‐196a targets the inhibitor of NFκB (NFKBIA).
Jesús García‐Castillo +8 more
wiley +1 more source
A generating function approach to HIV transmission with dynamic contact rates. [PDF]
Romero-Severson EO, Meadors GD, Volz EM.
europepmc +1 more source
Trading Strategies Generated Pathwise by Functions of Market Weights [PDF]
Ioannis Karatzas, Donghan Kim
openalex +1 more source
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine +10 more
wiley +1 more source
Evaluating Generating Functions for Periodic Multiple Polylogarithms via Rational Chen–Fliess Series [PDF]
Kurusch Ebrahimi-Fard +5 more
openalex +1 more source
Relations between exponential tails, moments and moment generating functions for random variables and vectors [PDF]
Yuriy Kozachenko +2 more
openalex +1 more source
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song +11 more
wiley +1 more source
Spectral library generating function for assessing spectrum-spectrum match significance. [PDF]
Wang M, Bandeira N.
europepmc +1 more source
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source

